{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:59:56Z","timestamp":1762160396149},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1981,3,1]],"date-time":"1981-03-01T00:00:00Z","timestamp":352252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1981,3]]},"DOI":"10.1007\/bf01664004","type":"journal-article","created":{"date-parts":[[2005,5,8]],"date-time":"2005-05-08T19:35:01Z","timestamp":1115580901000},"page":"39-59","source":"Crossref","is-referenced-by-count":44,"title":["Neurochemical effects of some ergot derivatives: A basis for their antiparkinson actions"],"prefix":"10.1007","volume":"51","author":[{"given":"R.","family":"Markstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"69","volume-title":"J. Neural Transm., Suppl. 16","author":"L. F. Agnati","year":"1980","unstructured":"Agnati, L. F., Fuxe, K.: On the mechanism of antiparkinsonian action of L-DOPA and bromocriptine: A theoretical and experimental analysis of dopamine receptor sub- and supersensitivity. J. Neural Transm., Suppl. 16, pp. 69\u201381. Wien-New York: Springer. 1980."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00426743","volume":"57","author":"H. R. B\u00fcrki","year":"1978","unstructured":"B\u00fcrki, H. R., Asper, H., Ruch, W., Z\u00fcger, P. E.: Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF 25-397 and 29-712. Effects on the metabolism of the biogenic amines in the brain of the rat. Psychopharmac.57, 227\u2013237 (1978).","journal-title":"Psychopharmac."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"442 to 444","DOI":"10.1136\/bmj.4.5942.442","volume":"4","author":"D. B. Calne","year":"1974","unstructured":"Calne, D. B., Teychenne, P. F., Claveria, L. E., Eastman, R., Greenacre, J. K., Petrie, A.: Bromocriptine in parkinsonism. Brit. med. J.4, 442 to 444 (1974).","journal-title":"Brit. med. J."},{"key":"CR4","unstructured":"Closse, A., Frick, W., Hauser, D., Sauter, A.: Characterization of3H-bromocriptine binding to calf caudate membranes. In: Psychopharmacology and Biochemistry of Neurotransmitter Receptors (Olsen, R. W., Yamamura, H. J., eds.). New York: Elsevier, North-Holland Press. In press."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.2042-7158.1973.tb10037.x","volume":"25","author":"H. Corrodi","year":"1973","unstructured":"Corrodi, H., Fuxe, K., H\u00f6kfelt, T., Lidbrink, P., Ungerstedt, U.: Effect of ergot drugs on central catecholamine neurons. Evidence for a stimulation of central dopamine neurons. J. Pharm. Pharmacol.25, 409\u2013412 (1973).","journal-title":"J. Pharm. Pharmacol."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM196702162760703","volume":"276","author":"G. C. Cotzias","year":"1967","unstructured":"Cotzias, G. C., van Waest, M. H., Schiffer, L. M.: Aromatic amino acids and modification of parkinsonism. New Engl. J. Med.276, 374\u2013379 (1967).","journal-title":"New Engl. J. Med."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/254070a0","volume":"254","author":"D. Dougan","year":"1975","unstructured":"Dougan, D., Wade, D., Mearrick, P.: Effects of L-DOPA metabolites at a dopamine receptor suggest a basis for \u201con-off\u201d effects in Parkinson's disease. Nature254, 70\u201371 (1975).","journal-title":"Nature"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H. Ehringer","year":"1960","unstructured":"Ehringer, H., Hornykiewicz, O.: Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankung des extrapyramidalen Systems. Klin. Wschr.38, 1236\u20131239 (1960).","journal-title":"Klin. Wschr."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00504756","volume":"309","author":"C. Euvrad","year":"1979","unstructured":"Euvrad, C., Premont, J., Oberlander, C., Boissier, J. R., Bockaert, J.: Is dopamine-sensitive adenylate cyclase involved in regulating the activity of striatal cholinergic neurons? Naunyn-Schmiedeberg's Arch. Pharmacol.309, 241\u2013245 (1979).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR10","first-page":"615","volume-title":"Handbook of Experimental Pharmacology, Vol. 49","author":"E. Fl\u00fcckiger","year":"1978","unstructured":"Fl\u00fcckiger, E., del Pozo, E.: Influence on the endocrine system. In: Handbook of Experimental Pharmacology, Vol. 49 (Berde, B., Schild, H. O., eds.), Ch. IX, pp. 615\u2013690. Berlin-Heidelberg-New York: Springer. 1978."},{"key":"CR11","first-page":"327","volume-title":"Advances in Neurobiology, Vol. 24","author":"A. K. Granerus","year":"1979","unstructured":"Granerus, A. K., Carlsson, A., Svanborg, A.: The aging neuron. Influence on symptomatology and therapeutic response in Parkinson's symptoms. In: Advances in Neurobiology, Vol. 24 (Parrier, L. J., Sourkes, T. L., B\u00e9dard, P. J., eds.), pp. 327\u2013334. New York: Raven Press. 1979."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0006-8993(80)90896-3","volume":"192","author":"P. Herrling","year":"1980","unstructured":"Herrling, P., Hull, C. D.: Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons. Brain Res.192, 441\u2013462 (1980).","journal-title":"Brain Res."},{"key":"CR13","unstructured":"Hauser, D., Frick, W., Sauter, A. (Sandoz Ltd., Preclinical Research, Basle): Personal communication."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"J. W. Kebabian","year":"1979","unstructured":"Kebabian, J. W., Calne, D. B.: Multiple receptors for dopamine. Nature277, 93\u201396 (1979).","journal-title":"Nature"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1073\/pnas.69.8.2145","volume":"69","author":"J. W. Kebabian","year":"1972","unstructured":"Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine sensitive adenylate cyclase in caudate nucleus of rat brain and its similarity to the dopamine receptors. Proc. Nat. Acad. Sci. U.S.A.69, 2145\u20132149 (1972).","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"CR16","volume-title":"The Rat Brain: A Stereotaxic Atlas","author":"J. F. R. K\u00f6nig","year":"1970","unstructured":"K\u00f6nig, J. F. R., Klippel, R. A.: The Rat Brain: A Stereotaxic Atlas. New York: Krieger. 1970."},{"key":"CR17","first-page":"639","volume":"12","author":"B. K. Kr\u00fcger","year":"1976","unstructured":"Kr\u00fcger, B. K., Forn, J., Walters, J. R., Roth, R. H.: Stimulation by dopamine of adenosine cyclic 3\u2032, 5\u2032-monophosphate formation in rat caudate nucleus: Effect of lesions of the nigro-neostriatal pathway. Mol. Pharmacol.12, 639\u2013648 (1976).","journal-title":"Mol. Pharmacol."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/272168a0","volume":"272","author":"J. E. Leysen","year":"1978","unstructured":"Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P., Laduron, P.: Serotoninergic component of neuroleptic receptors. Nature272, 168\u2013171 (1978).","journal-title":"Nature"},{"issue":"Suppl. 1","key":"CR19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000212303","volume":"24","author":"R. Markstein","year":"1978","unstructured":"Markstein, R., Wagner, H.: Effect of dihydroergotoxine on cyclic AMP-generating systems in rat cerebral cortex slices. Gerontology24, Suppl. 1, 94\u2013105 (1978).","journal-title":"Gerontology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0024-3205(80)90592-5","volume":"26","author":"P. R. Mitchell","year":"1980","unstructured":"Mitchell, P. R., Doggett, N. S.: Modulation of striatal3H-glutamic acid release by dopaminergic drugs. Life Sciences26, 2073\u20132081 (1980).","journal-title":"Life Sciences"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/274278a0","volume":"274","author":"I. I. Nagy","year":"1978","unstructured":"Nagy, I. I., Lee, T., Seeman, P., Fibiger, H. C.: Direct evidence for presynaptic and postsynaptic dopamine receptors in the brain. Nature274, 278\u2013281 (1978).","journal-title":"Nature"},{"key":"CR22","first-page":"804","volume":"14","author":"J. K. Northup","year":"1978","unstructured":"Northup, J. K., Mansour, T. E.: Adenylate cyclase from Fasciola hepatica. 1. Ligand specificity of adenylate cyclase coupled serotonin receptors. Mol. Pharmacol.14, 804\u2013819 (1978).","journal-title":"Mol. Pharmacol."},{"key":"CR23","first-page":"277","volume":"4","author":"H. O. Schild","year":"1949","unstructured":"Schild, H. O.: pAX and competitive drug antagonism. Br. J. Pharmacol.4, 277\u2013280 (1949).","journal-title":"Br. J. Pharmacol."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/271766a0","volume":"271","author":"R. Schwarcz","year":"1978","unstructured":"Schwarcz, R., Creese, J., Coyle, J. T., Snyder, S.: Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature271, 766\u2013768 (1978).","journal-title":"Nature"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0028-3908(76)90093-9","volume":"15","author":"J. Shoulson","year":"1976","unstructured":"Shoulson, J., Chase, T. N.: Clonidine and the antiparkinsonian response to L-DOPA or piribedil. Neuropharmacol.15, 25\u201327 (1976).","journal-title":"Neuropharmacol."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BFb0050157","volume":"77","author":"K. Starke","year":"1977","unstructured":"Starke, K.: Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmac.77, 1\u2013124 (1977).","journal-title":"Rev. Physiol. Biochem. Pharmac."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00497003","volume":"305","author":"K. Starke","year":"1978","unstructured":"Starke, K., Reimann, W., Zumstein, A., Hertting, G.: Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol.305, 27\u201336 (1978).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00501218","volume":"309","author":"J. C. Stoof","year":"1979","unstructured":"Stoof, J. C., Thieme, R. E., Vrijmoed de Vries, M. C., Mulder, A. H.: In vitro acetylcholine release from rat caudate nucleus as a new model for testing drugs with dopamine receptor activity. Naunyn-Schmiedeberg's Arch. Pharmacol.309, 119\u2013124 (1979).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR29","first-page":"431","volume":"82","author":"V. M. Tennysan","year":"1974","unstructured":"Tennysan, V. M., Heikkila, R., Mytilineou, C., Cote, L., Cohen, G.: 5-Hydroxydopamine \u201ctagged\u201d neuronal boutons in rabbit neostriatum: Interrelationship between vesicles and axonal membrane. Brain Res.82, 431\u2013438 (1974).","journal-title":"Brain Res."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0024-3205(78)90044-9","volume":"23","author":"L. J. Thal","year":"1978","unstructured":"Thal, L. J., Makman, M. H., Ahn, H. S., Mishra, R. K., Horowitz, S. G., Dvorkin, B., Katzman, R.:3H-spiroperidol binding and dopamine stimulated adenylate cyclase: Evidence for multiple classes of receptors in primate brain regions. Life Sciences23, 629\u2013634 (1978).","journal-title":"Life Sciences"},{"issue":"Suppl. 1","key":"CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000136817","volume":"16","author":"J. M. Vigouret","year":"1978","unstructured":"Vigouret, J. M., B\u00fcrki, H. R., Jaton, A.-L., Z\u00fcger, P. E., Loew, D.: Neurochemical and neuropharmacological investigations of four ergot derivatives: Bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712. Pharmacol.16, Suppl. 1, 156\u2013173 (1978 a).","journal-title":"Pharmacol."},{"key":"CR32","first-page":"931B","volume":"34","author":"J. M. Vigouret","year":"1980","unstructured":"Vigouret, J. M., Jaton, A. L., Wagner, H. R., Loew, D.: Attempt to correlate effects of ergot derivatives with central dopaminergic stimulant properties in functional tests. Experientia34, 931B (1980 b).","journal-title":"Experientia"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01664004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01664004\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01664004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T19:21:49Z","timestamp":1557256909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01664004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,3]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1981,3]]}},"alternative-id":["BF01664004"],"URL":"https:\/\/doi.org\/10.1007\/bf01664004","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,3]]}}}